144 results
Page 4 of 8
6-K
EX-99.1
mr684e8v5n5qnk 67fod
19 Oct 20
Current report (foreign)
8:10am
UPLOAD
d8i2wf3rhfd
9 Oct 20
Letter from SEC
12:00am
6-K
EX-99.1
egoo3n29 sqbd9179
7 Oct 20
Mereo BioPharma Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission
9:53am
F-3
EX-1.2
mqgx f76dmp4
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
rvdho906agcqkg5tmda
6 Oct 20
Shelf registration (foreign)
4:25pm
F-6EF
EX-99
5tch8nn4g210q748fen
6 Oct 20
Automatic registration for ADRs (foreign)
4:10pm
6-K
EX-99.2
tw6elx6dnsbvm9b1up6
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
5yt95 xdmbszg
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
p56yuuobbqxo
28 Sep 20
Mereo BioPharma Announces Changes to Board of Directors
8:08am
6-K
EX-99.1
spz 8yd2la
24 Sep 20
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation for Setrusumab for the Treatment of Osteogenesis Imperfecta
8:48am
6-K
EX-99.1
id3duobut7
25 Aug 20
Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
11:14am
UPLOAD
a4vcuwr m71k9vh
9 Jul 20
Letter from SEC
12:00am
F-3
zpim h5g0
6 Jul 20
Shelf registration (foreign)
4:58pm
6-K
EX-99.3
6qys5j
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
633 dbs5bgat
16 Jun 20
Current report (foreign)
4:13pm